Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genmab Gross Profit 2019-2019 | GMAB

Genmab gross profit from 2019 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Genmab Annual Gross Profit
(Millions of US $)
2018 $479
Genmab Quarterly Gross Profit
(Millions of US $)
Q3 2019 $155
Q2 2019 $117
Q4 2018
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.876B $0.479B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.231B 15.12
CSL (CSLLY) Australia $84.984B 0.00
Gilead Sciences (GILD) United States $82.323B 10.20
Celgene (CELG) United States $78.303B 11.18
Vertex Pharmaceuticals (VRTX) United States $53.950B 55.07
Biogen (BIIB) United States $50.933B 8.74
Illumina (ILMN) United States $44.980B 49.35
Regeneron Pharmaceuticals (REGN) United States $37.865B 16.58
Alexion Pharmaceuticals (ALXN) United States $23.981B 11.84
Seattle Genetics (SGEN) United States $19.667B 0.00
Incyte (INCY) United States $18.675B 43.35
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.479B 0.00
Genmab (GNMSF) Denmark $13.448B 59.40
Exact Sciences (EXAS) United States $10.653B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.263B 0.00
Galapagos (GLPG) Belgium $10.073B 25.95
BeiGene (BGNE) Cayman Islands $9.413B 0.00
QIAGEN (QGEN) Netherlands $9.147B 29.82
Amarin (AMRN) Ireland $8.580B 0.00
Bio-Techne Corp (TECH) United States $8.097B 54.20
Guardant Health (GH) United States $7.513B 0.00
Sarepta Therapeutics (SRPT) United States $7.265B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.101B 0.00
Moderna (MRNA) United States $6.455B 0.00
Reata Pharmaceuticals (RETA) United States $5.988B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.668B 14.41
ARGENX SE-ADR (ARGX) Netherlands $5.311B 0.00
Exelixis (EXEL) United States $5.017B 14.11
Ascendis Pharma (ASND) Denmark $4.741B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Repligen (RGEN) United States $4.408B 79.88
Spark Therapeutics (ONCE) United States $4.269B 0.00
Bluebird Bio (BLUE) United States $4.149B 0.00
Medicines (MDCO) United States $4.144B 0.00
Mirati Therapeutics (MRTX) United States $3.784B 0.00
Blueprint Medicines (BPMC) United States $3.707B 0.00
Adaptive Biotechnologies (ADPT) United States $3.545B 0.00
Immunomedics (IMMU) United States $3.391B 0.00
Alkermes (ALKS) Ireland $3.308B 0.00
MorphoSys AG (MOR) Germany $3.299B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.139B 0.00
Emergent Biosolutions (EBS) United States $2.830B 28.11
Halozyme Therapeutics (HALO) United States $2.771B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.692B 0.00
MyoKardia (MYOK) United States $2.540B 0.00
NeoGenomics (NEO) United States $2.513B 133.72
Amicus Therapeutics (FOLD) United States $2.440B 0.00
UniQure (QURE) Netherlands $2.306B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
Zai Lab (ZLAB) China $2.262B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Acceleron Pharma (XLRN) United States $2.175B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.084B 0.00
Cambrex (CBM) United States $2.018B 0.00
Ligand Pharmaceuticals (LGND) United States $1.893B 36.42
Myriad Genetics (MYGN) United States $1.840B 27.19
Akcea Therapeutics (AKCA) United States $1.813B 0.00
Insmed (INSM) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.586B 0.00
Denali Therapeutics (DNLI) United States $1.454B 0.00
Zymeworks (ZYME) Canada $1.423B 0.00
Epizyme (EPZM) United States $1.399B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.394B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
Coherus BioSciences (CHRS) United States $1.330B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.321B 0.00
Innoviva (INVA) United States $1.260B 3.71
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Editas Medicine (EDIT) United States $1.173B 0.00
Fate Therapeutics (FATE) United States $1.111B 0.00
Alector (ALEC) United States $1.101B 0.00
Sangamo Therapeutics (SGMO) United States $1.091B 0.00
Arvinas (ARVN) United States $1.029B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.000B 0.00
Zealand Pharma (ZEAL) Denmark $0.997B 0.00
Principia Biopharma (PRNB) United States $0.985B 0.00
WAVE Life Sciences (WVE) Singapore $0.983B 0.00
Athenex (ATNX) United States $0.901B 0.00
Codexis (CDXS) United States $0.881B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.875B 0.00
Anika Therapeutics (ANIK) United States $0.856B 27.78
Cara Therapeutics (CARA) United States $0.847B 0.00
Vericel (VCEL) United States $0.834B 310.83
Vanda Pharmaceuticals (VNDA) United States $0.824B 6.93
ZIOPHARM Oncology Inc (ZIOP) United States $0.806B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.722B 184.44
Twist Bioscience (TWST) United States $0.719B 0.00
Revance Therapeutics (RVNC) United States $0.713B 0.00
DBV Technologies S.A (DBVT) France $0.701B 0.00
ANI Pharmaceuticals (ANIP) United States $0.674B 11.49
MiMedx (MDXG) United States $0.653B 0.00
Intellia Therapeutics (NTLA) United States $0.650B 0.00
Precision BioSciences (DTIL) United States $0.615B 0.00
Mesoblast (MESO) Australia $0.609B 0.00
Adverum Biotechnologies (ADVM) United States $0.605B 0.00
Cellectis S.A (CLLS) France $0.574B 0.00
GENFIT S.A (GNFT) France $0.568B 0.00
Retrophin (RTRX) United States $0.556B 0.00
UROGEN PHARMA (URGN) United States $0.555B 0.00
BioDelivery Sciences (BDSI) United States $0.551B 0.00
Agenus (AGEN) United States $0.511B 0.00
Kadmon Holdings (KDMN) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.498B 0.00
Stemline Therapeutics (STML) United States $0.497B 0.00
Dynavax Technologies (DVAX) United States $0.489B 0.00
Cytokineticsorporated (CYTK) United States $0.483B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.473B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
AC Immune SA (ACIU) Switzerland $0.470B 10.88
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.368B 0.00
Bellus Health (BLU) Canada $0.363B 0.00
Arcus Biosciences (RCUS) United States $0.351B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
Clovis Oncology (CLVS) United States $0.350B 0.00
PDL BioPharma (PDLI) United States $0.343B 8.57
AMAG Pharmaceuticals (AMAG) United States $0.334B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.310B 0.00
Kindred Biosciences (KIN) United States $0.304B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Avid Bioservices (CDMO) United States $0.294B 0.00
Protagonist Therapeutics (PTGX) United States $0.290B 0.00
Compugen (CGEN) Israel $0.289B 0.00
Pfenex (PFNX) United States $0.279B 0.00
Theratechnologies (THTX) Canada $0.276B 0.00
Seres Therapeutics (MCRB) United States $0.271B 0.00
Gritstone Oncology (GRTS) United States $0.263B 0.00
Geron (GERN) United States $0.262B 0.00
Cel-Sci (CVM) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.247B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
CytomX Therapeutics (CTMX) United States $0.244B 0.00
Kamada (KMDA) Israel $0.238B 6.96
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
Albireo Pharma (ALBO) United States $0.231B 0.00
Scholar Rock Holding (SRRK) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.227B 0.00
XOMA (XOMA) United States $0.221B 0.00
Athersys (ATHX) United States $0.218B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Syros Pharmaceuticals (SYRS) United States $0.212B 0.00
Sorrento Therapeutics (SRNE) United States $0.204B 0.00
Cue Biopharma (CUE) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.195B 0.00
ChromaDex (CDXC) United States $0.189B 0.00
Affimed (AFMD) Germany $0.188B 0.00
Exicure (XCUR) United States $0.188B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.181B 4.95
Senesco Technologies (ELOX) United States $0.169B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.166B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Dyadic (DYAI) United States $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.149B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Enzo Biochem (ENZ) United States $0.138B 0.00
Alcobra (ARCT) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Cerecor (CERC) United States $0.132B 0.00
Mersana Therapeutics (MRSN) United States $0.131B 0.00
BioTime (LCTX) United States $0.130B 6.69
Emmaus Life Sciences (EMMA) United States $0.129B 0.00
Ophthotech (ISEE) United States $0.128B 0.00
Five Prime Therapeutics (FPRX) United States $0.128B 0.00
Fortress Biotech (FBIO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Aptinyx (APTX) United States $0.112B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Novavax (NVAX) United States $0.109B 0.00
NantKwest (NK) United States $0.108B 0.00
OvaScience (MLND) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
PHASEBIO PHARMA (PHAS) United States $0.102B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Aduro Biotech (ADRO) United States $0.089B 0.00
Acorda Therapeutics (ACOR) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.086B 0.00
Celyad SA (CYAD) Belgium $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Strongbridge Biopharma (SBBP) United States $0.086B 2.29
VTv Therapeutics (VTVT) United States $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.067B 0.00
Verastem (VSTM) United States $0.067B 0.00
Trevena (TRVN) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Organovo Holdings (ONVO) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.055B 3.56
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.051B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.97
Protalix BioTherapeutics (PLX) Israel $0.029B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.028B 0.00
Celsion (CLSN) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
VistaGen Therapeutics (VTGN) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00